BTG plc (LON:BTG – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 840 ($11.05) and traded as high as GBX 840 ($11.05). BTG shares last traded at GBX 840 ($11.05), with a volume of 271,742 shares trading hands.
BTG Stock Up 0.1 %
The firm’s 50-day simple moving average is GBX 840 and its 200-day simple moving average is GBX 840. The firm has a market capitalization of £3.26 billion and a P/E ratio of 29.47.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Read More
- Five stocks we like better than BTG
- What is a Stock Market Index and How Do You Use Them?
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- What is the Euro STOXX 50 Index?
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
